title: Hypersomnia, asterixis and cataplexy in association with orexin A-reduced hypothalamic tumor.
authors.forename: Kazuya
authors.initials: K
authors.lastname: Nokura
authors.forename: Takashi
authors.initials: T
authors.lastname: Kanbayashi
authors.forename: Toshihiko
authors.initials: T
authors.lastname: Ozeki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Koga
authors.forename: Takaaki
authors.initials: T
authors.lastname: Zettsu
authors.forename: Hiroko
authors.initials: H
authors.lastname: Yamamoto
authors.forename: Norio
authors.initials: N
authors.lastname: Ozaki
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Shimizu
authors.forename: Tsukasa
authors.initials: T
authors.lastname: Kawase
mesh_terms: D000368:Aged; D002385:Cataplexy / Q000209:etiology*; D006970:Disorders of Excessive Somnolence / Q000209:etiology*; D020820:Dyskinesias / Q000209:etiology*; D005260:Female; D006801:Humans; D007029:Hypothalamic Neoplasms / Q000134:cerebrospinal fluid* / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D047908:Intracellular Signaling Peptides and Proteins / Q000134:cerebrospinal fluid*; D008279:Magnetic Resonance Imaging; D009479:Neuropeptides / Q000134:cerebrospinal fluid*; D000068797:Orexins
chemical_list: C000596229:HCRT protein, human; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins